These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 9301503)
41. Evidence for the presence of two tumor suppressor genes on chromosome 8p for colorectal carcinoma. Fujiwara Y; Emi M; Ohata H; Kato Y; Nakajima T; Mori T; Nakamura Y Cancer Res; 1993 Mar; 53(5):1172-4. PubMed ID: 8439963 [TBL] [Abstract][Full Text] [Related]
42. A pilot study investigating the role of NAT1 and NAT2 polymorphisms in gastric adenocarcinoma. Boissy RJ; Watson MA; Umbach DM; Deakin M; Elder J; Strange RC; Bell DA Int J Cancer; 2000 Aug; 87(4):507-11. PubMed ID: 10918189 [TBL] [Abstract][Full Text] [Related]
43. NAT2*7 allele is a potential risk factor for adult brain tumors in Taiwanese population. Liu HE; Hsiao PY; Lee CC; Lee JA; Chen HY Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):661-5. PubMed ID: 18349284 [TBL] [Abstract][Full Text] [Related]
44. [N-actyltransferase2 polymorphism in recurrence of colorectal polyps and adenomas]. Zheng S; Liu X; Cao J Zhonghua Yi Xue Za Zhi; 2001 Aug; 81(15):907-9. PubMed ID: 11702663 [TBL] [Abstract][Full Text] [Related]
45. The arylamine N-acetyltransferase (NAT2) polymorphism and the risk of adverse reactions to co-trimoxazole in children. Zielińska E; Niewiarowski W; Bodalski J Eur J Clin Pharmacol; 1998; 54(9-10):779-85. PubMed ID: 9923584 [TBL] [Abstract][Full Text] [Related]
46. N-acetyltransferase 2 acetylation polymorphism: prevalence of slow acetylators does not differ between atopic dermatitis patients and healthy subjects. Brocvielle H; Muret P; Goydadin AC; Boone P; Broly F; Kantelip JP; Humbert P Skin Pharmacol Appl Skin Physiol; 2003; 16(6):386-92. PubMed ID: 14528063 [TBL] [Abstract][Full Text] [Related]
48. Refinement of the prediction of N-acetyltransferase 2 (NAT2) phenotypes with respect to enzyme activity and urinary bladder cancer risk. Selinski S; Blaszkewicz M; Ickstadt K; Hengstler JG; Golka K Arch Toxicol; 2013 Dec; 87(12):2129-39. PubMed ID: 24221535 [TBL] [Abstract][Full Text] [Related]
49. N-acetyltransferase-2 genotypes among Jordanian patients with diabetes mellitus. Irshaid YM; Abujbara MA; Ajlouni KM; El-Khateeb M; Jarrar YB Int J Clin Pharmacol Ther; 2013 Jul; 51(7):593-9. PubMed ID: 23587153 [TBL] [Abstract][Full Text] [Related]
50. Polymorphisms of glutathione-S-transferase and arylamine N-acetyltransferase enzymes and susceptibility to colorectal cancer. Kiss I; Németh A; Bogner B; Pajkos G; Orsós Z; Sándor J; Csejtey A; Faluhelyi Z; Rodler I; Ember I Anticancer Res; 2004; 24(6):3965-70. PubMed ID: 15736440 [TBL] [Abstract][Full Text] [Related]
51. Association between NAT2 polymorphisms and the risk of schizophrenia in a Northern Chinese Han population. Luan Z; Lu T; Yue W; Copray S; Zhang D Psychiatr Genet; 2017 Apr; 27(2):71-75. PubMed ID: 28187106 [TBL] [Abstract][Full Text] [Related]
52. NAT2 slow acetylator genotype as an important modifier of breast cancer risk. Sillanpää P; Hirvonen A; Kataja V; Eskelinen M; Kosma VM; Uusitupa M; Vainio H; Mitrunen K Int J Cancer; 2005 Apr; 114(4):579-84. PubMed ID: 15609332 [TBL] [Abstract][Full Text] [Related]
53. Genotype and allele frequencies of N-acetyltransferase 2 and glutathione S-transferase in the Iranian population. Torkaman-Boutorabi A; Hoormand M; Naghdi N; Bakhshayesh M; Milanian I Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1207-11. PubMed ID: 17880378 [TBL] [Abstract][Full Text] [Related]
54. N-acetyltransferase-2 genotypes among patients with rheumatoid arthritis attending Jordan University Hospital. Oqal MK; Mustafa KN; Irshaid YM Genet Test Mol Biomarkers; 2012 Sep; 16(9):1007-10. PubMed ID: 22731637 [TBL] [Abstract][Full Text] [Related]
55. Cigarette smoking, N-acetyltransferase genes and the risk of advanced colorectal adenoma. Moslehi R; Chatterjee N; Church TR; Chen J; Yeager M; Weissfeld J; Hein DW; Hayes RB Pharmacogenomics; 2006 Sep; 7(6):819-29. PubMed ID: 16981843 [TBL] [Abstract][Full Text] [Related]
56. Characterization of N-acetyltransferase 1 and 2 polymorphisms and haplotype analysis for inflammatory bowel disease and sporadic colorectal carcinoma. Mahid SS; Colliver DW; Crawford NP; Martini BD; Doll MA; Hein DW; Cobbs GA; Petras RE; Galandiuk S BMC Med Genet; 2007 May; 8():28. PubMed ID: 17537267 [TBL] [Abstract][Full Text] [Related]
57. GSTM1-null genotype as a risk factor for sporadic colorectal cancer in a Romanian population. Association with the NAT2-rapid-acetylator phenotype and exposure to environmental factors. Procopciuc LM; Osian G Cancer Invest; 2014 Feb; 32(2):53-62. PubMed ID: 24467372 [TBL] [Abstract][Full Text] [Related]
58. N-Acetyltransferase-2 (NAT2) genotype frequency among Jordanian volunteers. Jarrar YB; Ismail S; Irshaid YM Int J Clin Pharmacol Ther; 2010 Oct; 48(10):688-94. PubMed ID: 20875375 [TBL] [Abstract][Full Text] [Related]
59. N-acetyltransferase 2 genetic polymorphism: effects of carcinogen and haplotype on urinary bladder cancer risk. Hein DW Oncogene; 2006 Mar; 25(11):1649-58. PubMed ID: 16550165 [TBL] [Abstract][Full Text] [Related]
60. Combined effect of CYP1B1 codon 432 polymorphism and N-acetyltransferase 2 slow acetylator phenotypes in relation to breast cancer in the Turkish population. Ozbek YK; Oztürk T; Tüzüner BM; Calay Z; Ilvan S; Seyhan FM; Kisakesen HI; Oztürk O; Isbir T Anticancer Res; 2010 Jul; 30(7):2885-9. PubMed ID: 20683028 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]